Author/Authors :
Tomas de Paulis، نويسنده , , Bakula L. Trivedi، نويسنده , , Zhang-Jin Zhang، نويسنده , , Dennis E. Schmidt، نويسنده , , Michael H. Ebert، نويسنده , , William A. Hewlett، نويسنده ,
Abstract :
TRIZAC is one of the most potent 5-HT-3 receptor antagonist reported to date, having 20-fold higher affinity than (S)-5-todozacopride. This high affinity (K1 0.05 ± 0.01 nM) and a moderate apparent lipophilicity (log Papp 2.12) makes TRIZAC a promising ligand for studying 5-HT-3 receptors.